DBV Technologies S.A. DBVT

Updated: 17 Jun 2026

NASDAQ | Biotech | Epicutaneous immunotherapy for food allergies

No signal published yet

We already track DBV Technologies S.A. and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow DBV Technologies S.A. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Epicutaneous immunotherapy for food allergies
We're already tracking DBV Technologies S.A. — here are the latest events we've registered

Recent News

  • In June 2026, DBV Technologies presented positive data from its VITESSE Phase 3 study and announced the screening of the first participant in the THRIVE Phase 2 study for infants. The company also held its 2026 Combined General Meeting on June 3, where shareholders approved all proposed resolutions.

What Firelda Watch includes for DBV Technologies S.A.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of DBV Technologies S.A. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Want to follow DBV Technologies S.A.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow DBV Technologies S.A. free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

DBV Technologies S.A. DBVT
DBV Technologies S.A. — follow and we'll monitor it
Follow DBV Technologies S.A. free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.